Mexico City
,
Mexico
·
Latin America
Section 32 is a San Diego-based venture capital firm focused on seed, Series A, and Series B investments in healthcare and life sciences companies, founded by Bill Maris, who previously founded and led Google Ventures (GV) as its managing partner from 2009 to 2016. The firm invests with initial checks from $3 million to $20 million. Portfolio companies include Akili Interactive, the prescription digital therapeutic for ADHD; GRAIL, the multi-cancer early detection company acquired by Illumina and subsequently spun out as an independent public company; Nuvation Bio, the clinical-stage oncology company; and Recursion Pharmaceuticals, the AI-driven drug discovery company. Beyond its original investments, the portfolio includes additional healthcare and life science companies.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
